Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.

Abstract:

:Successfully translating anti-cancer nanomedicines from pre-clinical proof of concept to demonstration of therapeutic value in the clinic is challenging. Having made significant advances with drug delivery technologies, we must learn from other areas of oncology drug development, where patient stratification and target-driven design have improved patient outcomes. We should evolve our nanomedicine development strategies to build the patient and disease into the line of sight from the outset. The success of small molecule targeted therapies has been significantly improved by employing a specific decision-making framework, such as AstraZeneca's 5R principle: right target/efficacy, right tissue/exposure, right safety, right patient, and right commercial potential. With appropriate investment and collaboration to generate a platform of evidence supporting the end clinical application, a similar framework can be established for enhancing nanomedicine translation and performance. Building informative data packages to answer these questions requires the following: (I) an improved understanding of the heterogeneity of clinical cancers and of the biological factors influencing the behaviour of nanomedicines in patient tumours; (II) a transition from formulation-driven research to disease-driven development; (III) the implementation of more relevant animal models and testing protocols; and (IV) the pre-selection of the patients most likely to respond to nanomedicine therapies. These challenges must be overcome to improve (the cost-effectiveness of) nanomedicine development and translation, and they are key to establishing superior therapies for patients.

journal_name

Adv Drug Deliv Rev

authors

Hare JI,Lammers T,Ashford MB,Puri S,Storm G,Barry ST

doi

10.1016/j.addr.2016.04.025

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

25-38

eissn

0169-409X

issn

1872-8294

pii

S0169-409X(16)30135-1

journal_volume

108

pub_type

杂志文章,评审
  • Current oral and non-oral routes of antiepileptic drug delivery.

    abstract::Antiepileptic drugs are commonly given orally for chronic treatment of epilepsy. The treatment of epilepsy requires administration of medications for both acute and chronic treatment using multiple types of formulations. Parenteral routes are used when the oral route is unavailable or a rapid clinical response is requ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/j.addr.2012.01.017

    authors: Anderson GD,Saneto RP

    更新日期:2012-07-01 00:00:00

  • Proton therapy - Present and future.

    abstract::In principle, proton therapy offers a substantial clinical advantage over conventional photon therapy. This is because of the unique depth-dose characteristics of protons, which can be exploited to achieve significant reductions in normal tissue doses proximal and distal to the target volume. These may, in turn, allow...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.11.006

    authors: Mohan R,Grosshans D

    更新日期:2017-01-15 00:00:00

  • Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

    abstract::Synthetic polymer based Polyfectins (cationic polymer-DNA complex) have received intensive scientific research as they can potentially circumvent problems associated with viral vectors for gene therapy. These cationic macromolecules can readily condense DNA or RNA into stable nanostructures for use in gene delivery. R...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.09.008

    authors: Hunter AC

    更新日期:2006-12-01 00:00:00

  • Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery.

    abstract::Transferrin receptor has been an important protein for many of the advances made in understanding the intricacies of the intramolecular sorting pathways of endocytosed molecules. The unique internalization and recycling functions of transferrin receptor have also made it an attractive choice for drug targeting and del...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2003.07.004

    authors: Widera A,Norouziyan F,Shen WC

    更新日期:2003-11-14 00:00:00

  • Bone formation controlled by biologically relevant inorganic ions: role and controlled delivery from phosphate-based glasses.

    abstract::The role of metal ions in the body and particularly in the formation, regulation and maintenance of bone is only just starting to be unravelled. The role of some ions, such as zinc, is more clearly understood due to its central importance in proteins. However, a whole spectrum of other ions is known to affect bone for...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2012.05.015

    authors: Lakhkar NJ,Lee IH,Kim HW,Salih V,Wall IB,Knowles JC

    更新日期:2013-04-01 00:00:00

  • Antifolates targeted specifically to the folate receptor.

    abstract::Most antifolate drugs are efficiently transported by the reduced-folate carrier (RFC). However, several also bind with high affinity to the alpha-isoform of the folate receptor (alpha-FR) and there is evidence to suggest that this transport mechanism may contribute to their activity when the receptor is highly overexp...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2004.01.003

    authors: Jackman AL,Theti DS,Gibbs DD

    更新日期:2004-04-29 00:00:00

  • The transport of antiepileptic drugs by P-glycoprotein.

    abstract::Epilepsy is the most common serious chronic neurological disorder. Current data show that one-third of patients do not respond to anti-epileptic drugs (AEDs). Most non-responsive epilepsy patients are resistant to several, often all, AEDs, even though the drugs differ from each other in pharmacokinetics, mechanisms of...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2011.12.003

    authors: Zhang C,Kwan P,Zuo Z,Baum L

    更新日期:2012-07-01 00:00:00

  • Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond.

    abstract::Cell-based therapy is emerging as a promising strategy for treating a wide range of human diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and several types of cancer. Pancreatic islets, blood cells, hepatocytes, and stem cells are among the many cell types currently used for this ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.04.018

    authors: Farina M,Alexander JF,Thekkedath U,Ferrari M,Grattoni A

    更新日期:2019-01-15 00:00:00

  • Antibody-directed enzyme prodrug therapy (ADEPT): a review.

    abstract::Antibody-directed enzyme prodrug therapy (ADEPT) is a therapeutic strategy which aims to improve the selectivity of anticancer drugs. ADEPT is a two-step antibody targeting system that has benefits over a one-step chemo-, toxin- or radioimmunoconjugate. The basic principles of ADEPT are discussed alongside the require...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(97)00032-x

    authors: Springer CJ,Niculescu-Duvaz I I

    更新日期:1997-07-07 00:00:00

  • Pharmacogenomics and -genetics in colorectal cancer.

    abstract::Despite recent progress in our knowledge about the development and therapy of colorectal cancer (CRC), it still remains one of the major cancer related deaths throughout the world. With the introduction of new cytotoxic and targeting agents a significant improvement in progression-free and overall survival has been ac...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2008.10.002

    authors: Pohl A,Lurje G,Manegold PC,Lenz HJ

    更新日期:2009-05-20 00:00:00

  • Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases.

    abstract::A recombinant C-terminal truncated form of the human soluble tumor necrosis factor receptor type I (sTNF-RI) was produced in E. coli. This soluble receptor contains the first 2.6 of the 4 domains of the intact sTNF-RI molecule. A monoPEGylated form of this molecule was produced using a 30 kD methoxyPEG aldehyde with a...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(03)00112-1

    authors: Edwards CK 3rd,Martin SW,Seely J,Kinstler O,Buckel S,Bendele AM,Ellen Cosenza M,Feige U,Kohno T

    更新日期:2003-09-26 00:00:00

  • Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.

    abstract::The recent developments of nuclear medicine in oncology have involved numerous investigations of novel specific tumor-targeting radiopharmaceuticals as a major area of interest for both cancer imaging and therapy. The current progress in pharmaceutical nanotechnology field has been exploited in the design of tumor-tar...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2008.04.013

    authors: Hamoudeh M,Kamleh MA,Diab R,Fessi H

    更新日期:2008-09-01 00:00:00

  • Modulation of tight junction function by G protein-coupled events.

    abstract::Small G proteins or GTPases comprise a growing family of signal transduction molecules with inducible properties dependent upon reversible interactions with guanine nucleotides. Activation status of the proteins is characterized by preferential affinity for triphosphorylated guanine nucleotides, initiating signaling e...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(00)00050-8

    authors: Hopkins AM,Li D,Mrsny RJ,Walsh SV,Nusrat A

    更新日期:2000-06-30 00:00:00

  • Neural network based optimization of drug formulations.

    abstract::A pharmaceutical formulation is composed of several formulation factors and process variables. Several responses relating to the effectiveness, usefulness, stability, as well as safety must be optimized simultaneously. Consequently, expertise and experience are required to design acceptable pharmaceutical formulations...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(03)00120-0

    authors: Takayama K,Fujikawa M,Obata Y,Morishita M

    更新日期:2003-09-12 00:00:00

  • The structure of the choroid plexus and the physiology of the choroid plexus epithelium.

    abstract::The choroid plexuses (CPs) are leaf-like highly vascular structures laying in the ventricles. The main function of choroid plexuses is the production of the cerebrospinal fluid (CSF). Although CPs have a unique distribution of ion transporters/channels, the mechanism of CSF production is similar to the production of f...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2004.07.005

    authors: Redzic ZB,Segal MB

    更新日期:2004-10-14 00:00:00

  • Stem cell therapy clinical research: A regulatory conundrum for academia.

    abstract::The encouraging pace of discovery and development in the field of regenerative medicine holds tremendous potential for bringing therapies to the clinic that may offer meaningful benefit to patients, particularly in diseases with no or suboptimal therapeutic options. Academic researchers will continue to play a critica...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.10.001

    authors: Nagpal A,Juttner C,Hamilton-Bruce MA,Rolan P,Koblar SA

    更新日期:2017-12-01 00:00:00

  • Targeting podocyte-associated diseases.

    abstract::Injury to the podocytes is the initiating cause of many renal diseases, leading to proteinuria with possible progression to end-stage renal disease. Podocytes are highly specialized cells, with an important role in maintaining the glomerular filtration barrier and producing growth factors for both mesangial cells and ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2010.08.012

    authors: Leeuwis JW,Nguyen TQ,Dendooven A,Kok RJ,Goldschmeding R

    更新日期:2010-11-30 00:00:00

  • Formulation and delivery issues for monoclonal antibody therapeutics.

    abstract::Antibodies can have exquisite specificity of target recognition and thus generate highly selective outcomes following their systemic administration. While antibodies can have high specificity, the doses required to treat patients, particularly for a chronic condition, are typically large. Fortunately, advances in prod...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.03.011

    authors: Daugherty AL,Mrsny RJ

    更新日期:2006-08-07 00:00:00

  • Cardiovascular disease, chronopharmacotherapy, and the molecular clock.

    abstract::Cardiovascular functions such as heart rate and blood pressure show 24h variation. The incidence of cardiovascular diseases including acute myocardial infarction and arrhythmia also exhibits diurnal variation. The center of this circadian clock is located in the suprachiasmatic nucleus in the hypothalamus. However, re...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2010.04.011

    authors: Takeda N,Maemura K

    更新日期:2010-07-31 00:00:00

  • Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry.

    abstract::For poorly water soluble drugs, the amorphous state provides an avenue to enhance oral bioavailability. The preparation method, in addition to sample history, can dictate the nature and the stability of the amorphous phase. Conventionally, X-ray powder diffractometry is of limited utility for characterization, but str...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2015.12.013

    authors: Thakral S,Terban MW,Thakral NK,Suryanarayanan R

    更新日期:2016-05-01 00:00:00

  • Inner ear drug delivery for auditory applications.

    abstract::Many inner ear disorders cannot be adequately treated by systemic drug delivery. A blood-cochlear barrier exists, similar physiologically to the blood-brain barrier, which limits the concentration and size of molecules able to leave the circulation and gain access to the cells of the inner ear. However, research in no...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2008.08.001

    authors: Swan EE,Mescher MJ,Sewell WF,Tao SL,Borenstein JT

    更新日期:2008-12-14 00:00:00

  • Targeting drug delivery in the vascular system: Focus on endothelium.

    abstract::The bloodstream is the main transporting pathway for drug delivery systems (DDS) from the site of administration to the intended site of action. In many cases, components of the vascular system represent therapeutic targets. Endothelial cells, which line the luminal surface of the vasculature, play a tripartite role o...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2020.06.013

    authors: Glassman PM,Myerson JW,Ferguson LT,Kiseleva RY,Shuvaev VV,Brenner JS,Muzykantov VR

    更新日期:2020-01-01 00:00:00

  • Pain imaging: future applications to integrative clinical and basic neurobiology.

    abstract::We have entered a new era in understanding CNS circuitry involved in acute and chronic pain. The ability to objectively measure a pain or analgesic state of the brain using non-invasive methods that define neural activation provides the possibility for top-down approaches to drug discovery. These brain maps represent ...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0169-409x(03)00099-1

    authors: Borsook D,Becerra L

    更新日期:2003-08-28 00:00:00

  • Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.

    abstract::Newborn babies can require significant amounts of medication containing excipients intended to improve the drug formulation. Most medicines given to neonates have been developed for adults or older children and contain excipients thought to be safe in these age groups. Many excipients have been used widely in neonates...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/j.addr.2013.11.003

    authors: Turner MA,Duncan JC,Shah U,Metsvaht T,Varendi H,Nellis G,Lutsar I,Yakkundi S,McElnay JC,Pandya H,Mulla H,Vaconsin P,Storme T,Rieutord A,Nunn AJ

    更新日期:2014-06-01 00:00:00

  • Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis.

    abstract::Arthritis is presently incurable and poorly treatable, but there are good grounds for expecting gene therapy to improve matters considerably. Although local ex vivo delivery of anti-arthritic genes to the synovial lining of joints has shown considerable promise, intraarticular gene delivery may be desirable. Herpes si...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章

    doi:10.1016/s0169-409x(97)00021-5

    authors: Evans C,Goins WF,Schmidt MC,Robbins PD,Ghivizzani SC,Oligino T,Marconi P,Krisky D,Glorioso JC

    更新日期:1997-08-11 00:00:00

  • Chitosan-based formulations for delivery of DNA and siRNA.

    abstract::Among non-viral vectors, chitosan and chitosan derivatives have been developed in vitro and in vivo for DNA and siRNA delivery systems because of their cationic charge, biodegradability and biocompatibility, as well as their mucoadhesive and permeability-enhancing properties. However, the transfection efficiency of ch...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2009.08.004

    authors: Mao S,Sun W,Kissel T

    更新日期:2010-01-31 00:00:00

  • Fibrosis imaging: Current concepts and future directions.

    abstract::Fibrosis plays an important role in many different pathologies. It results from tissue injury, chronic inflammation, autoimmune reactions and genetic alterations, and it is characterized by the excessive deposition of extracellular matrix components. Biopsies are routinely employed for fibrosis diagnosis, but they suf...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2017.10.013

    authors: Baues M,Dasgupta A,Ehling J,Prakash J,Boor P,Tacke F,Kiessling F,Lammers T

    更新日期:2017-11-01 00:00:00

  • Role and modulation of drug transporters in HIV-1 therapy.

    abstract::Current treatment of human immunodeficiency virus type-1 (HIV-1) infection involves a combination of antiretroviral drugs (ARVs) that target different stages of the HIV-1 life cycle. This strategy is commonly referred to as highly active antiretroviral therapy (HAART) or combined antiretroviral therapy (cART). Membran...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2016.05.001

    authors: Alam C,Whyte-Allman SK,Omeragic A,Bendayan R

    更新日期:2016-08-01 00:00:00

  • Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

    abstract::Synthetic polymers and nanomaterials display selective phenotypic effects in cells and in the body signal transduction mechanisms involved in inflammation, differentiation, proliferation, and apoptosis. When physically mixed or covalently conjugated with cytotoxic agents, bacterial DNA or antigens, polymers can drasti...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2006.09.019

    authors: Kabanov AV

    更新日期:2006-12-30 00:00:00

  • Enhancing patient-level clinical data access to promote evidence-based practice and incentivize therapeutic innovation.

    abstract::Clinical trials are crucial to determining the human safety and efficacy of new therapeutic innovations. Extraordinary amounts of human experiential data are generated over the course of any clinical trial, however, much of these data is never made publicly accessible. Improved, reliable data sharing is essential to i...

    journal_title:Advanced drug delivery reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.addr.2018.01.017

    authors: Fortunato A,Grainger DW,Abou-El-Enein M

    更新日期:2018-01-01 00:00:00